High throughput screening for human interferon-γ production inhibitor using homogenous time-resolved fluorescence

被引:11
|
作者
Enomoto, K
Aono, Y
Mitsugi, T
Takahashi, K
Suzuki, R
Préaudat, M
Mathis, G
Kominami, G
Takemoto, H
机构
[1] Shionogi & Co Ltd, Chem Anal Labs, Toyonaka, Osaka 5610825, Japan
[2] Shionogi & Co Ltd, Discovery Res Labs, Toyonaka, Osaka 5610825, Japan
[3] Shionogi Inst Med Sci, Osaka, Japan
[4] CIS Bio Int, Gif Sur Yvette, France
关键词
D O I
10.1089/108705700416137
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An immunoassay for interferon-gamma (IFN-gamma) using homogeneous time-resolved fluorescence (HTRF) has been developed. In this assay, IFN-gamma can be detected by simply adding a mixture of three reagents-biotinylated polyclonal antibody, europium cryptate (fluorescence donor, EuK)-labeled monoclonal antibody, and crosslinked allophycocyanin (fluorescence acceptor, XL665) conjugated with streptavidin-and then measuring the time-resolved fluorescence. The detection limit of IFN-gamma by the proposed method is about 625 pg/ml, We applied the method to the detection of IFN-gamma secreted from NK3.3 cells and employed it in high throughput screening for IFN-gamma production inhibitors. With this screening format, IFN-gamma can be measured by directly adding the above reagents to microplate wells where NK3.3 cells are being cultured and stimulated with interleukin-12, This "in situ" immunoassay requires only pipetting reagents, with no need to transfer the culture supernatant to another microplate or wash the plate. Therefore, this screening format makes possible full automation of cell-based immunoassay, thus reducing cost and experimental time while increasing accuracy and throughput.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [41] Alignment of time-resolved data from high throughput experiments
    Abidi, Nada
    Franke, Raimo
    Findeisen, Peter
    Klawonn, Frank
    JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2016, 14 (06)
  • [42] TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY FOR HUMAN INTERFERON-GAMMA
    HARA, H
    CHIKUMA, M
    KOMINAMI, G
    ANALYTICAL SCIENCES, 1995, 11 (03) : 411 - 414
  • [43] Characterization of edible oils using time-resolved fluorescence
    Mu, Taotao
    Chen, Siying
    Zhang, Yinchao
    Chen, He
    Guo, Pan
    ANALYTICAL METHODS, 2014, 6 (03) : 940 - 943
  • [44] High throughput genetic analysis using time-resolved fluorometry and closed tube detection
    Nurmi, J
    Kiviniemi, M
    Kujanpää, M
    Sjöroos, M
    Ilonen, J
    Lövgren, T
    ANALYTICAL BIOCHEMISTRY, 2001, 299 (02) : 211 - 217
  • [45] TIME-RESOLVED FLUORESCENCE SPECTROSCOPY USING PULSED LASERS
    GHIGGINO, KP
    ROBERTS, AJ
    PHILLIPS, D
    JOURNAL OF PHYSICS E-SCIENTIFIC INSTRUMENTS, 1980, 13 (04): : 446 - 450
  • [46] A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions
    Kim, Beomkyu
    Tarchevskaya, Svetlana S.
    Eggel, Alexander
    Vogel, Monique
    Jardetzky, Theodore S.
    ANALYTICAL BIOCHEMISTRY, 2012, 431 (02) : 84 - 89
  • [47] A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential k-opioid receptor agonists
    Wang, Yue
    Yan, Ming
    Zheng, Guang-yao
    He, Ling
    Yang, Huan
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (07) : 957 - 966
  • [48] High-Throughput Screening for Actin-Binding Compounds that Affect Actomyosin Structure and Function using Time-Resolved FRET
    Guhathakurta, Piyali
    Prochniewicz, Ewa
    Peterson, Kurt C.
    Grant, Benjamin D.
    Gillispie, Gregory D.
    Thomas, David D.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 37A - 37A
  • [49] Screening for Optimal Liposome Preparation Conditions by Using Dual Centrifugation and Time-Resolved Fluorescence Measurements
    Koehler, Jonas K.
    Schnur, Johannes
    Heerklotz, Heiko
    Massing, Ulrich
    PHARMACEUTICS, 2021, 13 (12)
  • [50] TIME-RESOLVED FLUORESCENCE SPECTROSCOPY FOR INTRAOPERATIVE DELINEATION OF HUMAN GLIOMAS
    Butte, Pramod
    Mamelak, Adam N.
    Bannykh, Serguei
    Black, Keith L.
    Marcu, Laura
    NEURO-ONCOLOGY, 2009, 11 (05) : 697 - 698